We're sorry, but the study or condition you’re looking for is no longer available. You can search all currently enrolling studies or contact us if you have any questions.
Alpha-1 Antitrypsin Deficiency with Emphysema
Medical Condition
Alpha-1 Antitrypsin Deficiency
Facility/Clinic
PMG Research of Wilmington
Age
18-75
Gender
Male/Female
Description
A research study is evaluating an investigational medication that may slow the progression of alpha-1 antitrypsin deficiency in patients with emphysema.
This research study may be an option if you:
· Have a clinical diagnosis of alpha-1 antitrypsin deficiency
· Have evidence of emphysema
· Have been a non-smoker for at least 12 months
· Have no history of moderate to severe liver fibrosis
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.
Qualified participants will receive all study-related care and study medication at no cost.
Enrollment
Open
Patient Commitment Duration
Approximately 5 months
Patient Compensation
| Financial compensation may be provided for time and travel expenses. |
Number of visits in study
Approximately 9 clinic visits and 2 phone calls
10 1161 1
